NCT01086761 arm group 547830a58c1f141bf032d9d0c110718b [clinicaltrials_resource:NCT01086761/arm-group/547830a58c1f141bf032d9d0c110718b]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01086761 arm group 547830a58c1f141bf032d9d0c110718b [clinicaltrials_resource:NCT01086761/arm-group/547830a58c1f141bf032d9d0c110718b]
Bio2RDF identifier
NCT01086761/arm-group/547830a58c1f141bf032d9d0c110718b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 7830a58c1f141bf032d9d0c110718b
description [clinicaltrials_vocabulary:description]
Single 0.04 mg intravitreal injection of MP0112 in the study eye.
identifier
clinicaltrials_resource:NCT01086761/arm-group/547830a58c1f141bf032d9d0c110718b
title
NCT01086761 arm group 547830a58c1f141bf032d9d0c110718b
@en
type
label
NCT01086761 arm group 547830a5 ...... 830a58c1f141bf032d9d0c110718b]
@en